Photoaffinity analogs for multidrug resistance-related transporters and their use in identifying chemosensitizers

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Multidrug resistance (MDR) in cancer is a major obstacle, characterized by the overexpression of P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1).
• These proteins actively transport chemotherapeutic drugs out of cancer cells, leading to treatment failure.
• Identifying MDR-reversing agents (MDR modulators) that target P-gp and MRP1 is crucial for effective cancer therapy.

Purpose of the Study:

• To review the development and application of photoaffinity analogs for studying P-glycoprotein and MRP1.
• To discuss the identification, characterization, and localization of drug-binding sites on these MDR proteins.
• To highlight recent advances in understanding the structure of drug-binding sites on P-glycoprotein and novel MRP1 analogs.

Main Methods:

• Synthesis and use of radioactive photoaffinity analogs of vinblastine to explore P-glycoprotein drug-binding.
• Development of P-glycoprotein- and MRP-specific photoaffinity analogs.
• Application of photoaffinity analogs with site-directed antibodies to map drug-binding domains on P-glycoprotein.

Main Results:

• Photoaffinity analogs have been instrumental in identifying and characterizing drug-binding sites on P-glycoprotein and MRP1.
• General binding domains for cytotoxic agents and MDR modulators on P-glycoprotein have been localized.
• Recent advances have improved the delineation of P-glycoprotein drug-binding site structures.

Conclusions:

• Photoaffinity analogs are powerful tools for investigating MDR mechanisms and discovering novel MDR modulators.
• Further research is needed to fully elucidate the molecular architecture and exact location of drug-binding sites on P-glycoprotein.
• Novel MRP1 photoaffinity analogs represent a promising avenue for future research in overcoming multidrug resistance.